Below is a listing for all eMERGE studies currently submitted to and/or accessible in dbGaP.
| Accession Number | Study Description | Molecular Data Type | Release Date |
| phs000203 | Case/control study aiming to identify the generic variants mediating susceptibility to peripheral arterial disease (PAD). N= 3,337. | Whole Genome Genotyping | 11/05/2010 |
| phs000188 | Case set of participants exploring QRS duration on the electrocardiogram. N= 3,021. | Whole Genome Genotyping | 10/08/2011 |
| phs000408 | Case set containing data from the Geisinger eMERGE Genome-wide Association Study of Obesity Project. N= 962. | Whole Genome Genotyping | 12/06/2011 |
| phs000387 | Case set exploring the genetic determinants of Abdominal Aortic Aneurysm. N= 910. | Whole Genome Genotyping | 12/19/2011 |
| phs000381 | Control set of data from participants enrolled from community-based primary care clinics of Geisinger Health System. N= 1,231. | Whole Genome Genotyping | 12/19/2011 |
| phs000380 | Case set containing data from the Geisinger eMERGE Genome Wide Association Studies of Obesity (Metabochip). N= 982. | Whole Genome Genotyping | 01/12/2012 |
| phs000237 | Case/control study of data exploring the genetic determinants and race differences in prevalence of Type 2 Diabetes. N= 3,563. | Whole Genome Genotyping | 04/22/2012 |
| phs000494 | Cohort studies of data from participants enrolled across seven cohorts at Cincinnati Children’s Hospital. N= 4,562. | Whole Genome Genotyping | 07/23/2012 |
| phs000297 | Case/control study exploring the genetic determinants of resistant hypertension. N= 5,281. | Whole Genome Genotyping | 09/26/2012 |
| phs000495 | Prospective longitudinal study of participants enrolled in the Gene Partnership at Boston Children’s Hospital. N= 1,024. | Whole Genome Genotyping | 08/30/2013 |
| phs000490 | Case/control study of data exploring the genetic causes of complex pediatric disorders. N= 7,431. | Whole Genome Genotyping | 10/02/2013 |
| phs000170 | Case/control study exploring the genetic determinants of cataract and lipid abnormalities. N= 3,989. | Whole Genome Genotyping | 03/09/2015 |
| phs000948 | Cohort study containing data from participants, aged 50-65, enrolled at GroupHealth Cooperative. N= 1,968. | Whole Exome Genotyping | 08/28/2015 |
| phs000957 | Case/control exome chip study for Abdominal Aortic Aneurysm and extreme obesity. N= 9,212. | Whole Exome Genotyping | 11/16/2015 |
| phs000983.v1.p1 | Pharmacogenomics of Rheumatoid Arthritis Therapy. | Exome Genotyping | 01/21/2016 |
| phs000944 | Cross-sectional study of data from a subset of participants enrolled in the Partners Healthcare Biobank. N= 4,929. | Whole Genome Genotyping | 03/07/2016 |
| phs000963.v1.p1 | PGRN-RIKEN: Genetic Determinants of Clinical Cardiovascular Events in Patients Receiving Statins. | Targeted Genotyping | 05/16/2016 |
| phs000961 | Prospective case/control cohort study of participants enrolled in the Columbia University GENIE study. N= 3,065. | Whole Genome Genotyping | 06/07/2016 |
| phs000360 | Case/control study exploring the genetics determinants of five individual phenotypes. N= 18,663. | Targeted Genomic Sequencing | 08/11/2016 |
| phs000888 | A cohort study exploring the genetic determinants of more than 40 individual phenotypes (case/control sets included). N= 55,029. | Imputation | 08/11/2016 |
| phs000984.v1.p1 | Pharmacogenomics of Metformin Dose Response in T2DM Patients. | Exome Genotyping | 09/23/2016 |
| phs001011.v1.p1 | Case/control cohort study of data from participants enrolled across six cohorts at Cincinnati Children’s Hospital. N= 1,568. | Whole Genome Genotyping | 09/27/2016 |
| phs001191 | Longitudinal cohort study from Northwestern University’s NUgene project containing whole genome sequencing data. N= 900. | Whole Genome Sequencing | 10/03/2017 |
| phs000906 | Cohort study exploring clinical implementation of pharmacogenomics sequence data. N= 9,010. | Targeted Genomic Sequencing | 12/06/2017 |
| phs001165 | Longitudinal cohort study from the Children’s Hospital of Philadelphia containing whole genome sequencing data. N= 900. | Whole Genome Sequencing | 05/25/2018 |
| phs000234 | Case/control study focusing on dementia participants. N= 3,756. | Whole Genome Genotyping | 05/30/2018 |
| phs000571.v5.p2 | National Heart, Lung, and Blood Institute (NHLBI) Bench to Bassinet Program: The Pediatric Cardiac Genetics Consortium (PCGC). | Whole Exome Sequencing, Whole Genome Sequencing, & Targeted Sequencing | 09/14/2018 |
| phs001616.v2.p2 | eMERGE Network Phase III Clinical Sequencing: eMERGEseq Panel of 24,000 Participants. | Targeted Genomic Sequencing | 11/16/2020 |
| phs001584.v2.p2 | eMERGE Network Phase III: HRC SNV and 1000 Genomes SV Imputed Array Data of 105,000 Participants. | Imputation | 12/03/2020 |